Sobi launch Doptelet® (avatrombopag) in Europe ...Middle East

STOCKHOLM, Nov. 4, 2020 /PRNewswire/ -- Sobi™ Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announced the commercial launch of Doptelet® (avatrombopag) in Europe, with the United Kingdom as the first country for launch. Doptelet is a thrombopoietin receptor agonist (TPO-RA)...

Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi launch Doptelet® (avatrombopag) in Europe )

Also on site :

• De Anza College physical education complex to undergo $53 million renovation
• Rodeo man charged with kidnapping in East Bay home invasions
• Free People’s Viral Barrel Jeans Have the Internet Divided Over Their Stylishness (and They’re Almost Out of Stock)